Sarepta and Genethon Will Collaborate to Develop DMD Gene Therapy – Muscular Dystrophy News
|
Sarepta and Genethon Will Collaborate to Develop DMD Gene Therapy
Muscular Dystrophy News Sarepta Therpeutics and Genethon have signed a research collaboration agreement to jointly develop a gene therapy for Duchenne muscular dystrophy (DMD). Created by the AFM-Telethon, the French Muscular Dystrophy Association, Genethon is a … |
